News

IMAX CEO Sold Shares Worth $4.9 Million. Is the Stock a Buy or Sell?

Key PointsCEO Richard Gelfond sold 121,220 common shares for ~$4.86 million on March 10, 2026, at a weighted average price of around $40.10 per share.This disposition involved dire

Source  The Motley Fool1773620084
Infrastructure Stock Up 67% This Past Year Just Drew a New $6 Million Investment

Key PointsCandelo Capital Management initiated a 49,088-share position in Granite Construction during the fourth quarter.Post-trade, the quarter-end position for Granite Constructi

Source  The Motley Fool1773619411
SPXL vs. TQQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Buy for Leveraged ETF Investors?

Key PointsTQQQ and SPXL both use daily 3x leverage but track different indexes, leading to different sector exposures and performance patterns.TQQQ posted a higher one-year return

Source  The Motley Fool1773619097
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year

Key PointsSolas Capital Management added 460,619 shares of PRMB in the fourth quarter.The quarter-end position value increased by $7.53 million as a result.PRMB now accounts for 4.

Source  The Motley Fool1773618813
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue

Key PointsSolas Capital Management acquired 73,494 shares of Euronet Worldwide in the fourth quarter.The quarter-end position value increased by $5.59 million as a result of the ne

Source  The Motley Fool1773618396
Is Signet Jewelers Seriously Undervalued?

Key PointsSignet Jewelers makes and sells jewelry across a broad range of name brands.The stock has rallied strongly, pushing key valuation metrics to levels that suggest the value

Source  The Motley Fool1773617700
Target Is Cutting Prices on 3,000 Items As Inflation Drags Down Consumer Spending. Is Inflation Target Stock's Biggest Pain Point Right Now?

Key PointsTarget is viewed as a higher-quality store than Walmart, which is focused on everyday low prices.Target is cutting product costs, but the retailer's carefully honed image

Source  The Motley Fool1773617700
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment

Key PointsParkman bought 1,088,033 shares of EyePoint in the fourth quarter, marking a new stake for the fund.The quarter-end value of the EyePoint position increased by $19.88 mil

Source  The Motley Fool1773617123
2 Artificial Intelligence Stocks You Can Buy and Hold for the Next Decade

Key PointsWith the most complete AI stack, Alphabet is an AI stock to own for the long haul.Broadcom is one of the best growth stories in AI.10 stocks we like better than Alphabet

Source  The Motley Fool1773616800
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement

Key PointsParkman Healthcare Partners initiated a 200,000-share stake in Masimo during the fourth quarter.The quarter-end position value rose by $26.01 million as a result.Masimo i

Source  The Motley Fool1773616634
This Community Bank With $9 Billion in Assets Just Drew a $2.5 Million Investor Buy

Key PointsElizabeth Park Capital Advisors added 70,151 shares of OBK in the fourth quarter, an estimated $2.51 million trade based on average quarterly price.Meanwhile, the quarter

Source  The Motley Fool1773614774
The Most Overlooked Artificial Intelligence (AI) Stocks in the "Magnificent Seven" for 2026

Key PointsMicrosoft and Amazon operate the two largest cloud computing services.AI adoption hasn't reached 20% yet. 10 stocks we like better than Amazon › The "Magnificent Seven" i

Source  The Motley Fool1773614700
Regional Bank Stock Up 14% in a Year as Investor Sells $2.6 Million in Shares

Key PointsElizabeth Park Capital Advisors sold 23,200 shares of UMBF in the fourth quarter; the estimated transaction value was $2.63 million based on quarterly average prices.Mean

Source  The Motley Fool1773614386
Billionaires David Tepper and Michael Platt Sold Nvidia Shares and Bought This AI Stock That's Climbed 40,000% Since its IPO.

Key PointsRecent filings offer us a glimpse into the latest trades of some of the world’s top investors.Many of these investing giants have been piling into AI stocks. 10 stocks we

Source  The Motley Fool1773614100
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares

Key PointsOrbiMed Advisors sold 143,304 shares of Sionna Therapeutics in the fourth quarter; the estimated transaction value was $5.43 million based on quarterly average prices.Mea

Source  The Motley Fool1773613661
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share

Key PointsOrbiMed Advisors increased its position in RAPT Therapeutics by 556,273 shares during the fourth quarter; the estimated trade size was $17.28 million based on quarterly a

Source  The Motley Fool1773613240
Offshore Driller With $7.5 Billion Backlog Sees $6 Million Investor Trim Amid Staggering Stock Surge

Key PointsKerrisdale Advisers sold 204,364 shares of Noble Corporation in the fourth quarter; the estimated transaction value was $6.04 million based on quarterly average pricing.M

Source  The Motley Fool1773612449
Telecom Stock Up 25% Over the Past Year Draws $21 Million Bet From Hedge Fund

Key PointsKerrisdale Advisers bought 506,067 shares of TDS in the fourth quarter.The fund’s quarter-end stake in TDS increased by $20.75 million as a result of the new purchase.The

Source  The Motley Fool1773611974
Best Artificial Intelligence (AI) Stock to Buy Now: Nvidia vs. Palantir

Key PointsPalantir's software platform is a better long-term business model.Nvidia is capitalizing on massive AI spending. 10 stocks we like better than Palantir Technologies › Nvi

Source  The Motley Fool1773611700
Fidelity (FDVV) vs. ProShares (NOBL): Which Dividend ETF Reigns Supreme?

Key PointsFDVV charges a lower expense ratio and offers a higher dividend yield than NOBL.FDVV has delivered stronger one-year and five-year total returns, but with a slightly high

Source  The Motley Fool1773610683
Should You Buy Micron Before Earnings? Here's the 1 Thing That Matters.

Key PointsInvestors should focus on whether AI-driven memory shortage persists in 2026.Explosive demand for DRAM and HBM used in AI servers is driving up Micron’s top-line and bott

Source  The Motley Fool1773610440
Is a Sub-6% Mortgage Rate Enough to Make Buying in Retirement Worth It?

Key PointsIf you're selling a home before you move, you may have enough equity in the old home to get by with a small mortgage in the new one. As long as values appreciate, buying

Source  The Motley Fool1773609960
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy?

Key PointsBoone Capital Management purchased 212,856 shares of HealthEquity; trade value of $19.5 million as reported in the SEC filing.The position represents 6.12% of 13F reporta

Source  The Motley Fool1773609341
Boston Omaha Looks Cheap on Paper, but Weak Management Could Keep It a Value Trap

Key PointsBoston Omaha trades below its asset value, but weak capital allocation clouds that apparent bargain.Investors must weigh the NAV discount against absent catalysts and ong

Source  The Motley Fool1773608700
Top 2 Index Funds to Beat the S&P 500 Over the Next 5 Years, According to Wall Street

Key PointsFor years, the S&P 500 has easily delivered the best combination of earnings growth and investor performance.Later this year, smaller companies are finally expected to de

Source  The Motley Fool1773607800
What Drove Shiba Inu's Double-Digit Move Higher This Past Week?

Key PointsShiba Inu has seen a remarkable improvement off of its multi-year lows seen posted last week.In combination with improving sentiment more broadly, a number of token-speci

Source  The Motley Fool1773607775
Is American Express Stock a Millionaire Maker?

Key PointsYounger consumers are driving significant new card sign-ups for American Express.Management is targeting mid-teens earnings per share growth over the long run.The market

Source  The Motley Fool1773606900
2 No-Brainer AI Stocks to Buy Right Now

Key PointsThe current shifts in the AI infrastructure market are working in Broadcom's favor.Meta has been one of the best companies at applying AI to its core business to drive gr

Source  The Motley Fool1773606000
Oil at $100 Is a Bigger Threat to AI Stocks Than Most Investors Realize. Here's 1 Reason Why.

Key PointsOil prices have surged due to the rising conflict in the Middle East -- and that is having a ripple effect.Data centers use a ton of electricity, which tends to become mo

Source  The Motley Fool1773605100
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you?

Key PointsLogos added 1.1 million shares of Immunovant last quarter, a purchase estimated at about $24.5 million based on quarterly average pricing.By quarter's end, the position h

Source  The Motley Fool1773604776
goTop
quote